Analyst stock forecast
TG Therapeutics Forecast: $69.71 Analyst Target
TGTX has a $69.71 target, Strong Buy rating and 7 analysts. As of 2026-08-21.
Direct answer
TG Therapeutics's average price target is $69.71.
The target implies +26.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies -62%, the high target implies +55.6%, and the range spans 117.6% of the current price.
Forecast evidence checked August 21, 2026.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $55.26
- Average price target
- $69.71
- High price target
- $86.00
- Low price target
- $21.00
- Low target gap
- -62%
- Target upside
- +26.2%
- High target gap
- +55.6%
- Target range width
- 117.6%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is TG Therapeutics's average price target?
TG Therapeutics's verified average price target is $69.71. The target range is $21.00 to $86.00.
How far are TG Therapeutics's low and high targets from the recorded price?
The low target implies -62%, while the high target implies +55.6%.
How many analysts are included in TG Therapeutics's consensus?
The verified consensus includes 7 analysts.
How is TG Therapeutics's target upside or downside calculated?
The average target of $69.71 is divided by the recorded price of $55.26, then one is subtracted to produce +26.2%. This does not guarantee a future return.
When was TG Therapeutics's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.